Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 2,610 | 1,990 | 2,210 | 0 | 0 |
| Cost of Goods | 1,250 | 0 | N/A | 0 | 0 |
| Gross Profit | 1,360 | 1,990 | 2,210 | 0 | 0 |
| Operating Expenses | 12,010 | 13,480 | 10,320 | 6,642 | 4,139 |
| Operating Income | -10,400 | -11,490 | -8,110 | -6,642 | -4,139 |
| Interest Expense | 30 | 0 | 0 | 0 | 0 |
| Other Income | -10 | 0 | 0 | 684 | 421 |
| Pre-tax Income | -10,440 | -11,490 | -8,110 | -5,958 | -3,718 |
| Net Income Continuous | -10,400 | -11,500 | -8,100 | -5,958 | -3,718 |
| Net Income | $-10,440 | $-11,490 | $-8,110 | $-5,958 | $-3,718 |
| EPS Basic Total Ops | -244.90 | -271.31 | -199.28 | -250.73 | -220.75 |
| EPS Basic Continuous Ops | -244.71 | -270.59 | -199.02 | -250.73 | -220.75 |
| EPS Diluted Total Ops | -244.90 | -271.31 | -199.28 | N/A | N/A |
| EPS Diluted Continuous Ops | -244.71 | -270.59 | -199.02 | N/A | N/A |
| EBITDA(a) | $-10,350 | $-11,430 | $-8,110 | $-6,605 | $-4,125 |